Alternatives to placebo-controlled trials
- PMID: 17469680
- DOI: 10.1017/s0317167100005540
Alternatives to placebo-controlled trials
Abstract
Until recently, the gold standard for assessing the efficacy and effectiveness of new medications has been the placebo-control randomized clinical trial (RCT). However, there are serious ethical concerns about placing patients on a placebo when effective treatments exist. Further, if a new agent is tested only against a placebo, there is no guarantee that it is more effective, or even as effective, as an existing agent. For these and other reasons, ethicists and regulatory bodies have said that, under these circumstances, new drugs should be tested against an active agent. There are three types of such trials: superiority, equivalence, and non-inferiority. In superiority trials, the goal is to establish that the new drug is better (i.e., more effective, or with a more benign side-effect profile) than the standard. Because such trials require much larger sample sizes than placebo-control studies, and are rarely required to bring a drug onto market, they are rarely done. In equivalence trials, the aim is to show that the new and standard agents have similar degrees of effectiveness or adverse events. Due to sample size requirements, most studies of new drugs are non-inferiority trials, in which it is sufficient to demonstrate that the new drug is not significantly worse than the existing ones. However, there are methodological concerns with equivalence and non-inferiority trials, including (a) an inability to determine if the drugs were equally good or equally bad; (b) poorly executed trials with low power can be mistaken for "proving" equivalence or non-inferiority; (c) the equivalence interval is arbitrary; (d) successive non-inferiority trials may lead to a gradual reduction in effectiveness; and (e) often larger trials are necessary. The paper also discusses "add on trials." It is recommended that, even when existing drugs exist, trials should consist of at least three arms, one of which is a placebo. This paper briefly considers the ethics of placebo, and conditions are stated under which such studies can be conducted.
Similar articles
-
Methodology of superiority vs. equivalence trials and non-inferiority trials.J Hepatol. 2007 May;46(5):947-54. doi: 10.1016/j.jhep.2007.02.015. Epub 2007 Mar 9. J Hepatol. 2007. PMID: 17412447 Review.
-
The use of putative placebo in active control trials: two applications in a regulatory setting.Stat Med. 2003 Mar 30;22(6):941-52. doi: 10.1002/sim.1454. Stat Med. 2003. PMID: 12627411
-
Is it ethical to conduct placebo-controlled clinical trials in the development of new agents for osteoporosis? An industry perspective.J Bone Miner Res. 2003 Jun;18(6):1142-5. doi: 10.1359/jbmr.2003.18.6.1142. J Bone Miner Res. 2003. PMID: 12817772
-
Non-inferiority trials: design concepts and issues - the encounters of academic consultants in statistics.Stat Med. 2003 Jan 30;22(2):169-86. doi: 10.1002/sim.1425. Stat Med. 2003. PMID: 12520555
-
Methodological aspects of superiority, equivalence, and non-inferiority trials.Intern Emerg Med. 2020 Sep;15(6):1085-1091. doi: 10.1007/s11739-020-02450-9. Epub 2020 Jul 23. Intern Emerg Med. 2020. PMID: 32705494 Review.
Cited by
-
Early human screening of medications to treat drug addiction: novel paradigms and the relevance of pharmacogenetics.Clin Pharmacol Ther. 2011 Mar;89(3):460-3. doi: 10.1038/clpt.2010.254. Epub 2011 Jan 26. Clin Pharmacol Ther. 2011. PMID: 21270792 Free PMC article.
-
An efficient early phase 2 procedure to screen medications for efficacy in smoking cessation.Psychopharmacology (Berl). 2014 Jan;231(1):1-11. doi: 10.1007/s00213-013-3364-6. Epub 2013 Dec 3. Psychopharmacology (Berl). 2014. PMID: 24297304 Free PMC article. Review.
-
Head-to-head comparison of influenza vaccines in children: a systematic review and meta-analysis.J Transl Med. 2024 Oct 4;22(1):903. doi: 10.1186/s12967-024-05676-9. J Transl Med. 2024. PMID: 39367499 Free PMC article.
-
Rationale for and methods of superiority, noninferiority, or equivalence designs in orthopaedic, controlled trials.Clin Orthop Relat Res. 2011 Sep;469(9):2645-53. doi: 10.1007/s11999-011-1773-6. Epub 2011 Jan 19. Clin Orthop Relat Res. 2011. PMID: 21246313 Free PMC article. Review.
-
The clinical investigator-subject relationship: a contextual approach.Philos Ethics Humanit Med. 2009 Dec 3;4:16. doi: 10.1186/1747-5341-4-16. Philos Ethics Humanit Med. 2009. PMID: 19958542 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials